• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medication during pregnancy and breastfeeding is challenging for women with the condition. Little data exists about how long-term exposure to these drugs can affect the fetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus don't develop neurological developmental disorders like hearing or vision impairment, febrile seizures, or IQ impairment. The authors acknowledge that more high-quality studies are needed.

Risk/Benefit Analysis

Women who are pregnant and take ADHD medication need to weigh the benefits of taking it versus the risks to the fetus. Doctors don't have the information needed to make unequivocal recommendations however they can provide information about risks and benefits that assist pregnant women in making informed choices.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during their early pregnancy did not have a higher risk of fetal malformations, or structural birth defects. Researchers conducted a massive population-based case control study to assess the frequency of major structural defects in infants who were born to mothers who took stimulants during pregnancy. Pediatric cardiologists, clinical geneticists and other experts examined the cases to confirm that the classification was correct and to eliminate any bias.

The study of the researchers was not without its limitations. Most important, they were unable to separate the effects of the medication from the disorder at hand. This makes it difficult for researchers to determine whether the small associations observed among the groups that were exposed to the use of medications or if they were confounded by co-morbidities. In addition the study did not look at long-term offspring outcomes.

The study showed that infants whose mothers had taken ADHD medication during pregnancy had a slightly higher risk of admission to the neonatal care unit (NICU) as compared to mothers who didn't take any medication during pregnancy or had quit taking the medication prior to or during pregnancy. The reason for this was central nervous system disorders. The increased risk of admission was not influenced by the stimulant medication that was used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher chance of having to have a caesarean section or the baby was not scoring well on the Apgar scale (less than 7). These increases did appear to be unrelated to the type of medication used during pregnancy.

The research suggests that the low risk associated with the use of best adhd medication for someone with anxiety medications during early pregnancy may be offset by the greater benefit for both mother and child from continued treatment for the woman's disorder. Physicians should discuss this with their patients and, where possible, help them develop strategies to improve their coping abilities that can lessen the impact of her disorder on her daily functioning and relationships.

Medication Interactions

As more women than ever before are being diagnosed with ADHD and being treated with medication, the issue of whether to keep or stop treatment during pregnancy is a question that doctors are having to have to face. These decisions are frequently taken without clear and authoritative evidence. Instead, physicians must take into account their own experience and experience, as well as the experiences of other doctors, and the research that has been conducted on the subject.

The issue of possible risks to the infant can be particularly tricky. Many studies on this subject are based on observations rather than controlled research and their findings are often contradictory. Additionally, the majority of studies limit their analysis to live births, which may underestimate severe teratogenic effects that cause abortion or termination of the pregnancy. The study discussed in this journal club addresses these shortcomings by examining data on both live and deceased births.

Conclusion Some studies have shown a positive correlation between ADHD medications and certain birth defects however, other studies haven't established a link. Most studies have shown that there is a neutral, or slight negative impact. In the end, a careful risk/benefit analysis must be conducted in every situation.

It can be challenging, if not impossible, for women suffering from ADHD to stop taking their medication. In a recent article in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of isolation. A loss of medication may also affect the ability to drive safely and complete work-related tasks, which are essential aspects of daily life for those with ADHD.

She suggests that women who are not sure whether to take the medication or stop due to pregnancy, educate their family members, coworkers and acquaintances about the condition, its effects on daily functioning, and the benefits of continuing the current treatment regimen. Educating them can also help the woman feel supported in her struggle with her decision. Some medications can pass through the placenta. If a patient decides to not take her ADHD medication while pregnant and breastfeeding, it is important to be aware that the drug could be passed on to her infant.

Birth Defects and Risk of

As the use and misuse of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD), increases the concern over the potential adverse effects of the drugs on foetuses. A recent study published in the journal Molecular Psychiatry adds to the body types of adhd medication [Https://kennedy-silver-3.blogbright.net] information on this topic. Using two massive data sets researchers were able examine more than 4.3 million pregnancies to determine whether stimulant medications increased the risk of birth defects. Although the risk overall remains low, the scientists found that exposure in the first trimester to best adhd medication for women medications was linked to a slightly higher rate of specific heart defects, such as ventriculoseptal defect (VSD).

The researchers behind the study found no link between early use of medication and other congenital anomalies, such as facial clefting or club foot. The results are in agreement with previous studies that have shown a small, but significant increase in cardiac malformations for women who began taking adhd no medication medication prior to the time of the birth of their child. The risk was higher in the latter half of pregnancy, as many women decide to stop taking their medication.

Women who were taking ADHD medication in the first trimester were more likely require a caesarean delivery, have an insufficient Apgar after delivery and had a baby that required breathing assistance at birth. However the authors of the study were unable to eliminate selection bias by limiting the study to women who did not have any other medical issues that could have contributed to the findings.

The researchers hope that their research will help inform the clinical decisions of physicians who encounter pregnant women. The researchers recommend that while discussing benefits and risks are important, the choice regarding whether or not to stop medication should be made according to the severity of each woman's ADHD symptoms and her needs.

The authors also caution that while discontinuing the medications is an option, it isn't an option that is recommended due to the high incidence of depression and other mental health problems in women who are pregnant or recently post-partum. Additionally, the research suggests that women who choose to stop taking their medication are more likely to have a difficult time getting used to life without them following the birth of their baby.

Nursing

The responsibilities of being a new mother can be overwhelming. Women who suffer from ADHD can face severe challenges when they must deal with their symptoms, attend doctor appointments and prepare for the birth of their child and adjust to new routines. Therefore, many women choose to continue taking their ADHD medication throughout the pregnancy.

The risk to a breastfeeding infant is not too high since the majority of stimulant medication passes through breast milk at a low level. However, the rate of exposure to medication by the newborn may differ based on the dosage, frequency it is administered, and the time of the day the medication is administered. In addition, different medications are introduced into the baby's system via the gastrointestinal tract or through breast milk. The effect on a newborn's health is not completely known.

Some doctors may stop taking stimulant medication during a woman’s pregnancy due to the lack of research. This is a complicated decision for the patient, who must balance the benefits of continuing her medication with the potential risks to the fetus. As long as more information is available, doctors may ask pregnant patients whether they have any background of ADHD or if they intend to take medication in the perinatal period.

Numerous studies have proven that women can continue to take their ADHD medication safely during pregnancy and while breast-feeding. In response, a rising number of patients are choosing to continue their medication. They have discovered after consulting with their doctors that the benefits of continuing their current medication outweigh any risk.

It's important for women with ADHD who are contemplating breastfeeding to seek a specialist psychiatrist's advice prior to becoming pregnant. They should review their medications with their doctor and discuss the advantages and disadvantages of continued treatment, including non-pharmacological management strategies. Psychoeducation is also necessary to help pregnant women with ADHD recognize the signs and the underlying disorder. They should also learn about treatment options and strengthen the coping mechanisms. This should involve an approach that is multidisciplinary, including the GP doctors, obstetricians and psychiatrists. The pregnancy counselling should consist of the discussion of a plan for management for both the mother as well as the child, as well as monitoring for signs of deterioration and, if necessary, adjustments to the medication regimen.